Rivera, Christina G.
Zeuli, John D.
Smith, Bradley L.
Johnson, Tanner M.
Bhatia, Ramona
Otto, Ashley O.
Temesgen, Zelalem
Article History
Accepted: 18 October 2023
First Online: 11 December 2023
Declarations
:
: This work received no external funding.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: All authors contributed equally to this manuscript, read, and approved the final version.
: C.G.R. and B.L.S. have served on advisory board for Gilead Sciences, Inc., J.D.Z. has served on advisory boards for ViiV healthcare, Thera Technologies, and R.B. serves as advisory to the CDC on PrEP for the President’s Emergency Plan for AIDS Relief (PEPFAR) program.